These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1356 related items for PubMed ID: 19330734

  • 1. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H, Türkmen I, Başsüllü N, Dirican A, Karadağ N, Kirimlioğlu V.
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [Abstract] [Full Text] [Related]

  • 2. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
    Schmitz KJ, Lang H, Kaiser G, Wohlschlaeger J, Sotiropoulos GC, Baba HA, Jasani B, Schmid KW.
    Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
    [Abstract] [Full Text] [Related]

  • 3. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
    Riener MO, Vogetseder A, Pestalozzi BC, Clavien PA, Probst-Hensch N, Kristiansen G, Jochum W.
    Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
    [Abstract] [Full Text] [Related]

  • 4. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States.
    Welzel TM, McGlynn KA, Hsing AW, O'Brien TR, Pfeiffer RM.
    J Natl Cancer Inst; 2006 Jun 21; 98(12):873-5. PubMed ID: 16788161
    [Abstract] [Full Text] [Related]

  • 5. [Cholangiocarcinoma].
    Harder J, Blum HE.
    Praxis (Bern 1994); 2002 Aug 21; 91(34):1352-6. PubMed ID: 12233266
    [Abstract] [Full Text] [Related]

  • 6. Origin and pathological characteristics of Klatskin tumor: a case report and literature review.
    Somer L, Andrejić B, Milošević P.
    Pol J Pathol; 2012 Mar 21; 63(1):65-70. PubMed ID: 22535609
    [Abstract] [Full Text] [Related]

  • 7. [Gallbladder and bile duct carcinoma. Biology and pathology].
    Tannapfel A, Wittekind C.
    Internist (Berl); 2004 Jan 21; 45(1):33-41. PubMed ID: 14735242
    [Abstract] [Full Text] [Related]

  • 8. [Pathology of gallbladder and extrahepatic bile ducts. Case 6. Well- differentiated hilar cholangiocarcinoma pT2bN1].
    Guettier C.
    Ann Pathol; 2014 Aug 21; 34(4):309-14. PubMed ID: 25132442
    [No Abstract] [Full Text] [Related]

  • 9. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T, Okada Y, Nakanuma Y.
    Hepatology; 1996 Jun 21; 23(6):1341-4. PubMed ID: 8675149
    [Abstract] [Full Text] [Related]

  • 10. Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.
    Itatsu K, Zen Y, Yamaguchi J, Ohira S, Ishikawa A, Ikeda H, Sato Y, Harada K, Sasaki M, Sasaki M, Sakamoto H, Nagino M, Nimura Y, Ohta T, Nakanuma Y.
    Hum Pathol; 2008 May 21; 39(5):710-9. PubMed ID: 18329694
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathologic study of mixed adenoneuroendocrine carcinomas of hepatobiliary organs.
    Harada K, Sato Y, Ikeda H, Maylee H, Igarashi S, Okamura A, Masuda S, Nakanuma Y.
    Virchows Arch; 2012 Mar 21; 460(3):281-9. PubMed ID: 22358181
    [Abstract] [Full Text] [Related]

  • 12. Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma.
    Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Jang JY, Kim SW, Kang GH, Yoon YB.
    Ann Surg Oncol; 2007 Nov 21; 14(11):3195-201. PubMed ID: 17710498
    [Abstract] [Full Text] [Related]

  • 13. [Classification and staging systems for hilar cholangio-carcinoma (Klatskin tumors): clinical application and practical relevance].
    Gavrilovici V, Grecu F, Seripcariu V, Dragomir C.
    Rev Med Chir Soc Med Nat Iasi; 2011 Nov 21; 115(2):412-7. PubMed ID: 21870733
    [Abstract] [Full Text] [Related]

  • 14. Expression of matrix metalloproteinases in gallbladder carcinoma and their significance in carcinogenesis.
    Karadag N, Kirimlioglu H, Isik B, Yilmaz S, Kirimlioglu V.
    Appl Immunohistochem Mol Morphol; 2008 Mar 21; 16(2):148-52. PubMed ID: 18227728
    [Abstract] [Full Text] [Related]

  • 15. Adenocarcinoma of gallbladder: an immunohistochemical profile and comparison with cholangiocarcinoma.
    Hughes NR, Bhathal PS.
    J Clin Pathol; 2013 Mar 21; 66(3):212-7. PubMed ID: 23268317
    [Abstract] [Full Text] [Related]

  • 16. TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels.
    Surrey LF, Frank R, Zhang PJ, Furth EE.
    Am J Surg Pathol; 2014 Feb 21; 38(2):224-7. PubMed ID: 24418856
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
    Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham SC.
    Am J Surg Pathol; 2007 Jun 21; 31(6):907-13. PubMed ID: 17527079
    [Abstract] [Full Text] [Related]

  • 18. Pathological characteristics of early to advanced gallbladder carcinoma and extrahepatic cholangiocarcinoma.
    Kijima H, Wu Y, Yosizawa T, Suzuki T, Tsugeno Y, Haga T, Seino H, Morohashi S, Hakamada K.
    J Hepatobiliary Pancreat Sci; 2014 Jul 21; 21(7):453-8. PubMed ID: 24591403
    [Abstract] [Full Text] [Related]

  • 19. [Current diagnostics and therapy for carcinomas of the biliary tree and gallbladder].
    Wiedmann M, Schoppmeyer K, Witzigmann H, Hauss J, Mössner J, Caca K.
    Z Gastroenterol; 2005 Mar 21; 43(3):305-15. PubMed ID: 15765304
    [Abstract] [Full Text] [Related]

  • 20. The ratio of MMP-2 to TIMP-2 in hilar cholangiocarcinoma: a semi-quantitative study.
    Xiao M, Zhou NX, Huang ZQ, Lu YL, Chen LH, Wang DJ, Chang WL.
    Hepatobiliary Pancreat Dis Int; 2004 Nov 21; 3(4):599-602. PubMed ID: 15567754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.